20 Aug 2017 | 4:26 AM
 

Aurobindo Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524804 | NSE Symbol: AUROPHARMA
704.50
1.00
(0.15 %)
18 Aug 2017 | 03:48 PM
Change company
  • Open (Rs)
    703.55
  • Prev. close (Rs.)
    703.50
  • High (Rs.)
    708.70
  • Low (Rs.)
    687.50
  • 52W H (Rs.)
    895.00
  • 52W L (Rs.)
    504.00
  • Volume (Rs.)
    170869
  • MCap (Rs in Cr.)
    41,275.39
708
1.75
(0.25 %)
  • Open (Rs)
    703.35
  • High (Rs)
    710.90
  • Low (Rs)
    687.40
  • Prev. close(Rs)
    706.25
  • Contracts Tra.
    52,38,400
  • Turnover (Cr.)
    366
  • Open Interest
    1,30,34,400
  • Open Int. chg
    1,26,35,200.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
39.29
Operating Margin (%)
23.03
Gross Profit Margin (%)
20.16
Net Profit Margin (%)
15.43
Total Debt/Equity
0.33
Dividend payout Ratio (Net Profit)
5.96
Earning Retention Ratio
94.02

News

10 Aug 2017 - 11:54:00-Pharma major Aurobindo Pharma said that it is planning to increase its stake in Tergene Biotech whic...
09 Aug 2017 - 17:42:00-The company reported standalone net profit of Rs 307...
19 Jul 2017 - 11:33:00-Shares of drug maker Aurobindo Pharma rallied over 8 per cent on the Bombay stock Exchange after the...
19 Jul 2017 - 10:28:00-Leading pharma major Aurobindo Pharma Limited has said that the company has received final approval ...

Announcements

17-Aug-2017
Aurobindo Pharma - Analyst / Investor Meet - Intimation
08-Aug-2017
Aurobindo Pharma - Fixes Book Closure for AGM (Cut-off date for e-voting)
08-Aug-2017
Aurobindo Pharma - Updates
05-Aug-2017
Aurobindo Pharma - AGM/Book Closure
05-Aug-2017
Aurobindo Pharma - Analysts/Institutional Investor Meet/Con. Call Updates

Religare Research

18 Aug 2017 | 06:05 PM
Nifty recovered marginally in the passing week and gained over a percent. Sentiment was upbeat for m...
18 Aug 2017 | 04:47 PM
This week, we haven’t initiated fresh position, citing excessive volatility and possibility of furth...
18 Aug 2017 | 01:56 PM
Srikalahasthi Pipes Ltd (SPL) reported in-line numbers on the profit front with 14.7% & 15.2% YoY de...
18 Aug 2017 | 09:52 AM
The Indian rupee recouped most of its losses to end little changed against the dollar in thin tradin...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
94,96,996 715.12 54.80 -1.06
94,96,996 715.12 583.68 -1.06
94,96,996 715.12 604.87 -1.05
94,96,996 715.12 57.30 -1.06
48,31,294 363.80 440.13 -0.98

Shareholding Pattern

       
Promotors51.87%
Mutual Funds/UTI13.62%
FI/Banks0.56%
Insurance0.56%
FII19.62%
Government0.00%
Others4.31%

Peer Group

Company Intraday Graph
 Piramal Enterprises Ltd.
2,688.00(-1.13)
3356
 GlaxoSmithKline Pharmaceuticals Ltd.
2,390.00(0.21)
3317
 Dr. Reddy`s Laboratories Ltd.
1,982.90(-1.35)
3294
 Alkem Laboratories Ltd.
1,793.00(-1.46)
17141

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Aurobindo Pharma Ltd.-29.25103.7034.95
NIFTY(S&P CNX)10.25407.95958.20
BSE SENSEX-186.311,089.892,863.10
BSE 50013.92510.061,443.19

Corporate Details

Key Personal
Avnit Bimal Singh
Non Exe. & Ind. Director
D Rajagopala Reddy
Non Exe. & Ind. Director
K Nithyananda Reddy
Vice Chairman & Whole Time Dir
Key Address
Registered Office
Plot No.2 Maitri Vihar Ameerpet,Hyderabad,Telangana

Tel:040-23736370 66725000, Fax:040-23747340 67074059

info@aurobindo.com
http://www.aurobindo.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Aurobindo Pharma Ltd. that will help you decide whether to buy, sell or hold Aurobindo Pharma Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Aurobindo Pharma Ltd.